Venoocclusive disease due to chemotherapy for pediatric acute lymphoblastic leukemia is associated with increased levels of plasminogen-activator inhibitor-1
Venoocclusive disease due to chemotherapy for pediatric acute lymphoblastic leukemia is associated with increased levels of plasminogen-activator inhibitor-1
(2018)
Venoocclusive disease due to chemotherapy for pediatric acute lymphoblastic leukemia is associated with increased levels of plasminogen-activator inhibitor-1
We describe three cases of sinusoidal obstruction syndrome/venoocclusive disease (SOS) in pediatric patients with acute lymphoblastic leukemia (ALL). All three episodes occurred during or just after the induction or reinduction phase of treatment based on prednisone/dexamethasone, vincristine, daunorubicin, and pegylated-l-asparaginase. SOS episodes were categorized as mild/moderate and resolved in 7, 10, and 16 days using supportive measures or defibrotide therapy. In all three episodes, the clinical diagnosis of SOS was associated with a significant increase in plasminogen-activator inhibitor-1 (PAI-1) that reduced with patient clinical improvement. PAI-1 warrants study as a diagnostic marker for SOS in ALL.
Product ID:
109274
Handle IRIS:
11562/997256
Last Modified:
November 15, 2022
Bibliographic citation:
Mauro, Margherita; Saggiorato, Graziella; Sartori, Maria Teresa; Gallo, Giuseppe; De Bortoli, Massimiliano; Bonetti, Elisa; Zaccaron, Ada; Vitale, Virginia; Balter, Rita; Chinello, Matteo; Cesaro, Simone,
Venoocclusive disease due to chemotherapy for pediatric acute lymphoblastic leukemia is associated with increased levels of plasminogen-activator inhibitor-1«PEDIATRIC BLOOD & CANCER»
, vol. 65
, n. 6
, 2018
, pp. 26963-26966